Synthaverse S.A. (WSE:SVE)
Poland · Delayed Price · Currency is PLN 2.750
-0.030 (-1.08%)
Jul 24, 2026, 5:03 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 208.37 million as of July 24, 2026. Its market cap has decreased by -41.58% in one year.
Market Cap
208.37M
Enterprise Value
290.69M
Revenue
42.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.75
ChartMarket Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 208.37M, an increase of 44.70%. That is a compound annual growth rate of 2.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 208.37M | -19.33% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 585.29M |
| Bioceltix | 542.16M |
| Captor Therapeutics Spolka Akcyjna | 479.05M |
| Ryvu Therapeutics | 346.80M |
| BIOTON | 330.15M |
| Poltreg | 138.45M |
| Molecure | 122.59M |
| Mabion | 119.12M |